Literature DB >> 24975483

Pediatric inpatient hospital resource use for congenital heart defects.

Regina M Simeone1, Matthew E Oster, Cynthia H Cassell, Brian S Armour, Darryl T Gray, Margaret A Honein.   

Abstract

BACKGROUND: Congenital heart defects (CHDs) occur in approximately 8 per 1000 live births. Improvements in detection and treatment have increased survival. Few national estimates of the healthcare costs for infants, children and adolescents with CHDs are available.
METHODS: We estimated hospital costs for hospitalizations using pediatric (0-20 years) hospital discharge data from the 2009 Healthcare Cost and Utilization Project Kids' Inpatient Database (KID) for hospitalizations with CHD diagnoses. Estimates were up-weighted to be nationally representative. Mean costs were compared by demographic factors and presence of critical CHDs (CCHDs).
RESULTS: Up-weighting of the KID generated an estimated 4,461,615 pediatric hospitalizations nationwide, excluding normal newborn births. The 163,980 (3.7%) pediatric hospitalizations with CHDs accounted for approximately $5.6 billion in hospital costs, representing 15.1% of costs for all pediatric hospitalizations in 2009. Approximately 17% of CHD hospitalizations had a CCHD, but it varied by age: approximately 14% of hospitalizations of infants, 30% of hospitalizations of patients aged 1 to 10 years, and 25% of hospitalizations of patients aged 11 to 20 years. Mean costs of CHD hospitalizations were higher in infancy ($36,601) than at older ages and were higher for hospitalizations with a CCHD diagnosis ($52,899). Hospitalizations with CCHDs accounted for 26.7% of all costs for CHD hospitalizations, with hypoplastic left heart syndrome, coarctation of the aorta, and tetralogy of Fallot having the highest total costs.
CONCLUSION: Hospitalizations for children with CHDs have disproportionately high hospital costs compared with other pediatric hospitalizations, and the 17% of hospitalizations with CCHD diagnoses accounted for 27% of CHD hospital costs.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Kids' Inpatient Database; healthcare resource use; heart defects, congenital; hospital costs

Mesh:

Year:  2014        PMID: 24975483      PMCID: PMC4422978          DOI: 10.1002/bdra.23262

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  21 in total

1.  The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.

Authors:  William F McGhan; Maiwenn Al; Jalpa A Doshi; Isao Kamae; Steven E Marx; Donna Rindress
Journal:  Value Health       Date:  2009-09-10       Impact factor: 5.725

2.  Temporal trends in survival among infants with critical congenital heart defects.

Authors:  Matthew E Oster; Kyung A Lee; Margaret A Honein; Tiffany Riehle-Colarusso; Mikyong Shin; Adolfo Correa
Journal:  Pediatrics       Date:  2013-04-22       Impact factor: 7.124

3.  Racial and temporal variations in the prevalence of heart defects.

Authors:  L D Botto; A Correa; J D Erickson
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

4.  Strategies for implementing screening for critical congenital heart disease.

Authors:  Alex R Kemper; William T Mahle; Gerard R Martin; W Carl Cooley; Praveen Kumar; W Robert Morrow; Kellie Kelm; Gail D Pearson; Jill Glidewell; Scott D Grosse; R Rodney Howell
Journal:  Pediatrics       Date:  2011-10-10       Impact factor: 7.124

5.  Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-01-19       Impact factor: 17.586

6.  Racial variation in the quality of surgical care for prostate cancer.

Authors:  Daniel A Barocas; Darryl T Gray; Jay H Fowke; Nathaniel D Mercaldo; Jeffrey D Blume; Sam S Chang; Michael S Cookson; Joseph A Smith; David F Penson
Journal:  J Urol       Date:  2012-08-16       Impact factor: 7.450

7.  Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease.

Authors:  Roberta G Williams; Gail D Pearson; Robyn J Barst; John S Child; Pedro del Nido; Welton M Gersony; Karen S Kuehl; Michael J Landzberg; Merle Myerson; Steven R Neish; David J Sahn; Amy Verstappen; Carole A Warnes; Catherine L Webb
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

8.  Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.

Authors:  Mark D Reller; Matthew J Strickland; Tiffany Riehle-Colarusso; William T Mahle; Adolfo Correa
Journal:  J Pediatr       Date:  2008-07-26       Impact factor: 4.406

9.  The importance of nomenclature for congenital cardiac disease: implications for research and evaluation.

Authors:  Matthew J Strickland; Tiffany J Riehle-Colarusso; Jeffrey P Jacobs; Mark D Reller; William T Mahle; Lorenzo D Botto; Paige E Tolbert; Marshall L Jacobs; Francois G Lacour-Gayet; Christo I Tchervenkov; Constantine Mavroudis; Adolfo Correa
Journal:  Cardiol Young       Date:  2008-12       Impact factor: 1.093

10.  Measuring the cost of neonatal and perinatal care.

Authors:  J Rogowski
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

View more
  37 in total

1.  Healthcare Data Analytics for Parkinson's Disease Patients: A Study of Hospital Cost and Utilization in the United States.

Authors:  Sunanda Mukherjee; Huanmei Wu; Josette Jones
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Factors Associated with Readmission of Patients with Congenital Heart Disease in a Swiss University Hospital.

Authors:  Morgane Chave; Pedro Marques-Vidal
Journal:  Pediatr Cardiol       Date:  2017-02-02       Impact factor: 1.655

3.  Maternal Chlamydia Infection During Pregnancy and Risk of Cyanotic Congenital Heart Defects in the Offspring.

Authors:  Diane Y Dong; José N Binongo; Vijaya Kancherla
Journal:  Matern Child Health J       Date:  2016-01

4.  Factors associated with inpatient hospitalizations among patients aged 1 to 64 years with congenital heart defects, Arkansas 2006 to 2011.

Authors:  Regina M Simeone; Matthew E Oster; Charlotte A Hobbs; James M Robbins; R Thomas Collins; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-07-14

5.  Population-based study of hospital costs for hospitalizations of infants, children, and adults with a congenital heart defect, Arkansas 2006 to 2011.

Authors:  Regina M Simeone; Matthew E Oster; Charlotte A Hobbs; James M Robbins; R Thomas Collins; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-10

Review 6.  Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status.

Authors:  Joseph D Drews; Hideki Miyachi; Toshiharu Shinoka
Journal:  Trends Cardiovasc Med       Date:  2017-06-21       Impact factor: 6.677

7.  Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells.

Authors:  Michael Balistreri; Justin A Davis; Katherine F Campbell; André Monteiro Da Rocha; Marjorie C Treadwell; Todd J Herron
Journal:  Pediatr Cardiol       Date:  2017-07-27       Impact factor: 1.655

8.  Intravascular Ultrasound Characterization of a Tissue-Engineered Vascular Graft in an Ovine Model.

Authors:  Victoria K Pepper; Elizabeth S Clark; Cameron A Best; Ekene A Onwuka; Tadahisa Sugiura; Eric D Heuer; Lilamarie E Moko; Shinka Miyamoto; Hideki Miyachi; Darren P Berman; Sharon L Cheatham; Joanne L Chisolm; Toshiharu Shinoka; Christopher K Breuer; John P Cheatham
Journal:  J Cardiovasc Transl Res       Date:  2017-01-17       Impact factor: 4.132

9.  Proportion of selected congenital heart defects attributable to recognized risk factors.

Authors:  Regina M Simeone; Sarah C Tinker; Suzanne M Gilboa; A J Agopian; Matthew E Oster; Owen J Devine; Margaret A Honein
Journal:  Ann Epidemiol       Date:  2016-10-26       Impact factor: 3.797

10.  Pulse oximetry screening for critical congenital heart defects in Ontario, Canada: a cost-effectiveness analysis.

Authors:  Amit Mukerji; Amy Shafey; Amish Jain; Eyal Cohen; Prakesh S Shah; Beate Sander; Vibhuti Shah
Journal:  Can J Public Health       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.